CADL vs TXN · $592.0M cap vs P/E 52, rev $10.29B
Candel Therapeutics Inc (CADL) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ. It is led by Haviv Ilan.
CADL does not have a complete income-statement cache yet.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
CADL currently screens at market cap $592.0M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the CADL and TXN stock pages for the full models.
Not investment advice.